169 related articles for article (PubMed ID: 32715960)
21. ACMT Position Statement: Medication Shortages During Coronavirus Disease Pandemic.
Mazer-Amirshahi M; Fox ER; Farmer BM; Stolbach AI
J Med Toxicol; 2020 Jul; 16(3):346-348. PubMed ID: 32418120
[No Abstract] [Full Text] [Related]
22. Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future.
Kuo S; Ou HT; Wang CJ
J Am Pharm Assoc (2003); 2021; 61(1):e12-e15. PubMed ID: 32919923
[TBL] [Abstract][Full Text] [Related]
23. Hospital pharmacist experience in a multidisciplinary team in special care settings.
Santolaya-Perrin R; García-Martín Á; Carrero-Fernández A; Torres-Santos-Olmo R
Farm Hosp; 2020 Jun; 44(7):36-39. PubMed ID: 32533668
[TBL] [Abstract][Full Text] [Related]
24. The role of the critical care pharmacist during the COVID-19 pandemic.
Lemtiri J; Matusik E; Cousein E; Lambiotte F; Elbeki N
Ann Pharm Fr; 2020 Nov; 78(6):464-468. PubMed ID: 33038310
[TBL] [Abstract][Full Text] [Related]
25. Pharmaceutical care in hospitalized patients. (Management of the COVID-19 pandemic crisis. A new challenge for pharmacy services).
Sevilla-Sánchez D; Tuset-Creus M
Farm Hosp; 2020 Jun; 44(7):28-31. PubMed ID: 32533666
[TBL] [Abstract][Full Text] [Related]
26. Drug Shortages and the Defense Production Act.
Raunig BL; Kesselheim AS; Darrow JJ
Am J Public Health; 2020 Oct; 110(10):1504-1505. PubMed ID: 32903085
[No Abstract] [Full Text] [Related]
27. Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study.
De Weerdt E; De Rijdt T; Simoens S; Casteels M; Huys I
PLoS One; 2017; 12(3):e0174556. PubMed ID: 28350827
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy.
Margusino-Framiñán L; Illarro-Uranga A; Lorenzo-Lorenzo K; Monte-Boquet E; Márquez-Saavedra E; Fernández-Bargiela N; Gómez-Gómez D; Lago-Rivero N; Poveda-Andrés JL; Díaz-Acedo R; Hurtado-Bouza JL; Sánchez-Gundín J; Casanova-Martínez C; Morillo-Verdugo R
Farm Hosp; 2020 Jun; 44(7):61-65. PubMed ID: 32533674
[TBL] [Abstract][Full Text] [Related]
29. The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic.
Fox ER; Stolbach AI; Mazer-Amirshahi M
J Med Toxicol; 2020 Jul; 16(3):311-313. PubMed ID: 32458230
[No Abstract] [Full Text] [Related]
30. Applications of 3D Printing Technology to Address COVID-19-Related Supply Shortages.
Ishack S; Lipner SR
Am J Med; 2020 Jul; 133(7):771-773. PubMed ID: 32330492
[No Abstract] [Full Text] [Related]
31. Pharmacy Department management and organization.
Herranz-Alonso A; Rodríguez-González CG; Sarobe-González C; Álvarez-Díaz A; Sanjurjo-Sáez M
Farm Hosp; 2020 Jun; 44(7):5-10. PubMed ID: 32533661
[TBL] [Abstract][Full Text] [Related]
32. Specialized pharmaceutical care in social health centers in the times of COVID-19.
Peris-Martí JF; Bravo-José P; Sáez-Lleó C; Fernández-Villalba E
Farm Hosp; 2020 Jun; 44(7):43-48. PubMed ID: 32533670
[TBL] [Abstract][Full Text] [Related]
33. Managing the risk of shortages and medication errors with curares during the COVID-19 pandemic: a hospital pharmacy experience.
Bohand X; Jordan D; Dubois F
Eur J Hosp Pharm; 2023 Dec; 31(1):79-81. PubMed ID: 33789989
[TBL] [Abstract][Full Text] [Related]
34. Maintaining comprehensive pharmacy services during a pandemic: Recommendations from a designated COVID-19 facility.
Sin JH; Richards II; Ribisi MS
Am J Health Syst Pharm; 2020 Sep; 77(18):1522-1528. PubMed ID: 32533829
[TBL] [Abstract][Full Text] [Related]
35. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies.
Badreldin HA; Atallah B
Res Social Adm Pharm; 2021 Jan; 17(1):1946-1949. PubMed ID: 32446652
[TBL] [Abstract][Full Text] [Related]
36. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
Kirschenbaum BE
Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
[TBL] [Abstract][Full Text] [Related]
37. Advancing ambulatory pharmacy practice through a crisis: Objectives and strategies used in an ambulatory care action team's response to the COVID-19 pandemic.
Do T; Luon S; Boothe K; Stutsky M; Renauer M
Am J Health Syst Pharm; 2021 Mar; 78(8):720-725. PubMed ID: 33647947
[TBL] [Abstract][Full Text] [Related]
38. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
[TBL] [Abstract][Full Text] [Related]
39. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
Shah M; Sachdeva M; Dodiuk-Gad RP
Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251
[No Abstract] [Full Text] [Related]
40. Pharmacies on the Frontline: Responding to the COVID-19 Pandemic.
McElhiney LF
Int J Pharm Compd; 2020; 24(4):287-295. PubMed ID: 32649301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
